Why can’t you get more funding?
Also, and I understand that we never really know the upside with fundamental research, but what’s the upside? Why wouldn’t pharma or biotech see advantages to the research?
Also, and I understand that we never really know the upside with fundamental research, but what’s the upside? Why wouldn’t pharma or biotech see advantages to the research?
Edit to address the upside question: This is dynamic quantitative data with which you would eventually get at how much of a protein interacts with how much of another, where and when during cell division. Basically, this is getting at the dynamics of protein interactions in live cells. The goal would be to build an dynamic molecular interaction network of cell division.